Gut Microbiota as Targets for Preventing Ovalbumin-Induced Food Allergy

TL;DR

This study explores how gut bacteria might be targeted to prevent ovalbumin-induced food allergies, suggesting that increasing certain bacteria like Lachnospiraceae could be protective.

Contribution

The paper identifies Lachnospiraceae as a potential therapeutic target and shows that narirutin increases its abundance in the gut.

Findings

Lachnospiraceae is a potential therapeutic target for food allergy intervention.

Narirutin administration increases the abundance of Lachnospiraceae and Lachnospiraceae_NK4A136_group.

The protective effects of narirutin may be linked to increased Lachnospiraceae abundance, though the exact mechanism is unclear.

Abstract

Background: Ovalbumin (OVA) is a major allergen in egg whites. Introduction: Given the crucial role of gut microbiota in OVA-induced allergy, it remains unclear whether gut microbiota could serve as a therapeutic target for OVA allergy prevention. Method: To investigate the relationship between gut microbiota and food allergy, a two-sample bidirectional Mendelian randomization approach was combined combined with gut microbiota diversity analysis in vivo. Statistical analysis was performed, with p < 0.05 considered statistically significant and p < 0.01 highly significant. Results and discussion: Notably, Lachnospiraceae represents a potential therapeutic target for food allergy intervention, but the discrepancy between the MR and experimental findings highlights the limitations of the current research. When targeting the genus Lachnospiraceae, we observed that narirutin administration increased the abundance of the family Lachnospiraceae and the genus Lachnospiraceae_NK4A136_group. Conclusions: Narirutin may exert protective effects by increasing Lachnospiraceae abundance, but its precise mechanism—particularly whether it depends on SCFAs—requires further investigation.

Figures